ARHGDIA-ERBB3 Fusion FISH Probe
The ARHGDIA-ERBB3 Fusion FISH Probe is used to confirm a fusion of the ARHGDIA and ERBB3 genes. The fusion of the ARHGDIA and ERBB3 genes has been associated with Head And Neck Squamous Cell Carcinoma . These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ARHGDIA-ERBB3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ARHGDIA-ERBB3-20-AQAQ | 20 (40 μL) | 200 μL |
|
ARHGDIA Gene Summary
This gene encodes a protein that plays a key role in the regulation of signaling through Rho GTPases. The encoded protein inhibits the disassociation of Rho family members from GDP (guanine diphosphate), thereby maintaining these factors in an inactive state. Activity of this protein is important in a variety of cellular processes, and expression of this gene may be altered in tumors. Mutations in this gene have been found in individuals with nephrotic syndrome, type 8. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Gene Name: Rho GDP Dissociation Inhibitor Alpha
Chromosome: CHR17: 79825596 -79829282
Locus: 17q25.3
ERBB3 Gene Summary
This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
Gene Name: Erb-b2 Receptor Tyrosine Kinase 3
Chromosome: CHR12: 56473808 -56497291
Locus: 12q13.2
Gene Diseases
The ARHGDIA ERBB3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Head And Neck Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|